Recent study has pointed out that ATF6α-knockout mice show enhanced hepatic steatosis caused by impaired formation of VLDL due to destabilized apoB100, whereas the exact mechanism of ATF6 in regulating apoB100 formation still remains unclear (Yamamoto et al., 2010). The gene discussed is APOB; the disease is fatty liver disease.